07/25/2025
Simtra BioPharma Solutions has purchased a 65-acre property near our Bloomington, Indiana manufacturing site, paving the way for future expansion of our injectable manufacturing capabilities in North America.
As demand for advanced therapies like next generation oncology treatments continues to grow, this investment positions Simtra to serve our customers with greater flexibility and scale, while creating new opportunities for high-quality life sciences jobs.
Learn more about our plans and how this strategic move builds on our global expertise: https://www.prnewswire.com/news-releases/simtra-biopharma-solutions-announces-strategic-purchase-to-expand-us-manufacturing-capacity-for-injectable-medicines-302513753.html
We’re Made for This.
/PRNewswire/ -- Simtra BioPharma Solutions, a leading global contract development and manufacturing (CDMO) specializing in injectable medicines, announced...